1
Indications & Patient Selection
Sciatica, oncologic pain, piriformis syndrome, phantom limb
Indications
- Refractory sciatica (failed conservative management + epidural steroid injections)
- Oncologic pain in sciatic distribution: pelvic tumor directly involving or compressing sciatic nerve (colorectal, endometrial, sarcoma, sacral metastasis)
- Post-amputation phantom limb pain — cryoneurolysis of residual limb sciatic nerve
- Piriformis syndrome — sciatic nerve compression by hypertrophied piriformis; piriformis injection/Botox as first step; perisciatic injection as adjunct
- Diagnostic nerve block before cryoablation to confirm target
- Palliative pain control in terminal cancer with intractable sciatic-distribution pain refractory to opioids
Contraindications
- Uncorrectable coagulopathy
- Pre-existing complete sciatic nerve injury (no diagnostic value; ablation may worsen functional outcome)
- Patients requiring immediate full ambulation post-procedure (complete motor block expected — foot drop for 6–12 h after block, weeks after cryo)
- Active gluteal/sciatic soft tissue infection
- Negative diagnostic block (cryoablation will not provide benefit)
Block vs. Cryoablation vs. Piriformis Injection
| Indication | Preferred Approach | Notes |
|---|---|---|
| Diagnostic / first-line therapeutic | Perisciatic block (bupivacaine ± steroid) | Confirms sciatic distribution; assess motor effect before ablation |
| Piriformis syndrome | Piriformis intramuscular injection (Botox ± bupivacaine) | Target piriformis muscle bulk, not sciatic nerve; Botox 50–100 units + 10 mL LA |
| Refractory benign sciatica / phantom limb | Cryoablation (perisciatic, subgluteal) | Reversible; nerve regeneration 6–8 wks; preferred over chemical neurolysis |
| Oncologic pain (unresectable tumor) | Cryoablation ± chemical neurolysis | Longer-acting for limited life expectancy; discuss motor deficit expectations |
2
Pre-Procedure Planning
Imaging, labs, motor function baseline, consent
Imaging
- MRI pelvis/lumbar spine — characterize nerve compression source; rule out disc herniation or central canal stenosis amenable to neurosurgery
- MR neurography if available — assess sciatic nerve signal and caliber; T2 hyperintensity = active inflammation/injury
- CT pelvis for planning — visualize greater trochanter, ischial tuberosity, subgluteal space geometry
- For oncologic cases: recent CT or PET-CT to document tumor extent and nerve involvement
Assessment & Labs
- Baseline neurologic exam: document motor strength (hip flexion, knee extension, dorsiflexion, plantar flexion) and sensory distribution before procedure
- Nerve conduction velocity (NCV) / EMG for complex or post-surgical cases
- INR, platelet count (SIR Cat 1: INR ≤2.5, plt ≥25K)
- Fall risk assessment — physical therapy consult for high-risk patients before cryoablation
- AFO brace procurement for cryoablation cases (expected foot drop)
Baseline motor exam documented. Dorsiflexion, plantar flexion, hip flexion strength recorded for comparison post-procedure.
Diagnostic block performed for cryoablation planning. Confirm ≥50% pain relief for ≥24 h.
Motor deficit counseling completed. Patient understands expected temporary foot drop (days–weeks depending on modality). AFO brace available or ordered.
Fall precautions arranged. Crutches or walker available; home safety assessment; no driving post-procedure.
Physical medicine & rehab (PM&R) contacted for cryoablation cases — PT/OT plan for motor recovery period.
3
Anatomy
Sciatic nerve course, subgluteal space, CT landmarks
Nerve Origin & Course
- Largest nerve in the body; formed from L4–S3 nerve roots of the lumbosacral plexus
- Exits pelvis through greater sciatic foramen, below piriformis muscle (piriformis variant: nerve passes through or above piriformis — seen in ~15%)
- Subgluteal space: runs between greater trochanter (lateral) and ischial tuberosity (medial) under gluteus maximus — optimal CT-guided access point
- Descends in posterior thigh; divides into tibial nerve (medial) and common peroneal nerve (lateral) at popliteal fossa
- Posterior femoral cutaneous nerve (PFCN) runs alongside sciatic in subgluteal space — may be co-blocked; fat plane between PFCN and ischial tuberosity is distinct target
CT Landmarks & Motor Distribution
- Subgluteal approach: needle targets perineural fat between greater trochanter (lateral) and ischial tuberosity (medial), posterolateral to sciatic nerve
- Sciatic nerve appears as elliptical structure with internal fascicular architecture (fascicles visible on CT) in the perisciatic fat
- Tibial division: plantar flexion, toe flexion, posterior leg sensation
- Common peroneal division: dorsiflexion, eversion — foot drop if injured/blocked
- Proximal approach (ischial spine level): larger nerve cross-section; more predictable spread; used for oncologic or high-level entrapment
4
Technique
CT-guided subgluteal block and cryoablation
Supplies
22G Chiba needle (block)
Dilute contrast (10%)
0.5% bupivacaine 5–10 mL
Triamcinolone 40 mg (optional)
Extension tubing
Standard sterile tray + lidocaine 1%
17G cryoprobe (ablation)
Cryoablation console + argon supply (ablation)
CT fluoroscopy suite
Botox 50–100 units (piriformis injection)
CT-Guided Subgluteal Approach (Block)
1
Positioning & CT Planning
Prone positioning. CT planning scan through gluteal region — identify subgluteal space between greater trochanter (lateral) and ischial tuberosity (medial). Measure depth and angle for needle trajectory. Mark skin entry point in gluteal fat posterolateral to the sciatic nerve.
2
Skin Prep & Local Anesthesia
Standard sterile prep over gluteal region. 1% lidocaine skin wheal and subcutaneous track through gluteal fat. Note: avoid injecting LA too deep near nerve before block — will confound assessment of nerve position by causing inadvertent partial block.
3
Needle Advancement to Perisciatic Fat
Advance 22G Chiba needle through gluteal fat into subgluteal space. Target perineural fat plane posterior and lateral to the sciatic nerve fascicles. Intermittent CT confirms trajectory. Needle tip should be adjacent to but NOT within nerve fascicles.
4
Intraneural Check + Aspiration
If patient reports sharp electric-shock pain or paresthesia radiating down leg during advancement — withdraw 2–3 mm (intraneural placement). Aspirate — must be negative for blood. CT confirmation of needle tip in perisciatic fat plane.
5
Contrast Injection Test
Inject 0.5–1 mL dilute contrast. CT confirms perineural spread (injectate tracks along fascicular surface, surrounds nerve). If vascular opacification: reposition needle before proceeding.
6
Medication Injection
Inject 5–10 mL 0.5% bupivacaine for diagnostic or therapeutic block. For therapeutic block: add triamcinolone 40 mg. Inject slowly over 1–2 minutes monitoring for pain (intraneural) or systemic symptoms (intravascular). Complete block expected within 15–20 minutes.
7
Post-Injection Motor Exam
Assess dorsiflexion and plantar flexion strength at 15–20 minutes post-injection. Complete motor block expected with perineural bupivacaine — document for comparison to baseline. Warn patient before transfer: foot drop present, do not weight-bear unassisted.
Piriformis Injection Variant
1
Target Piriformis Muscle Belly
For piriformis syndrome: target center of piriformis muscle bulk (NOT sciatic nerve). CT identifies piriformis between greater sciatic notch (lateral) and sacrum (medial). Needle placed centrally in muscle. Inject Botox 50–100 units + 6 mL 1% lidocaine + 4 mL 0.5% bupivacaine. Goal: shrink hypertrophied muscle and reduce nerve compression.
▶ CT-guided sciatic nerve cryoablation
Sciatic nerve cryoablation for phantom limb pain: probe positioned perineurally at piriformis level — ice ball should encompass nerve without involving adjacent vascular structures.
Cryoablation Variant (After Positive Diagnostic Block)
1
17G Cryoprobe Placement
Advance 17G cryoprobe via subgluteal approach to perisciatic fat adjacent to sciatic nerve. CT confirms probe tip position. Probe should parallel nerve course for maximum ice ball coverage along nerve length.
2
Freeze-Thaw-Freeze Protocol
Two freeze cycles ≥8 minutes each, separated by 3–5 min passive thaw: freeze-thaw-freeze (8–10 min / 3–5 min / 8–10 min). Adequate duration ensures Wallerian degeneration (cessation of conduction, microtubule dissolution). Shorter freezes = partial ablation = risk of allodynia or incomplete relief.
3
Ice Ball Monitoring
Ice ball visible as low-density zone on CT. Must encompass sciatic nerve in transverse plane. Monitor for ice ball extension toward adjacent structures (femoral head, gluteal vessels). Post-freeze CT at completion confirms ablation zone.
4
Active Thaw & Probe Removal
Complete active thaw until probe freely mobile before withdrawal. Final CT confirms no hematoma. Document motor exam immediately post-procedure (dorsiflexion and plantar flexion). Provide AFO brace if foot drop present.
Community Cards
Sign in to view and create community cards
5
Troubleshooting
Intraneural injection, piriformis variant, inadequate block
Needle Position
Intraneural Placement
Sharp radiating pain to leg on needle advancement or injection = intraneural. Withdraw immediately 2–3 mm without injecting. Reconfirm position on CT — needle tip should be in perineural fat plane. If resistance to injection felt: intraneural; stop and reposition before proceeding.
Needle Position
Intravascular Injection
Aspiration of blood or rapid washout of contrast on CT test → reposition. Gluteal artery or sciatic vascular bundle can be adjacent. If systemic symptoms develop after injection (metallic taste, tinnitus, cardiovascular instability): intravascular local anesthetic — resuscitation protocol; no further injection at this site.
Piriformis Variant
Block at Ischial Tuberosity Not Effective
If subgluteal block provides incomplete or no relief: consider piriformis syndrome — nerve compression above subgluteal space. Target piriformis muscle with Botox injection at greater sciatic notch level. Alternatively, target nerve more proximally at ischial spine/sciatic notch level.
Cryoablation
Ice Ball Not Adequately Covering Nerve
On CT monitoring: ice ball offset or insufficient. Active thaw and reposition probe parallel to nerve course — longer probe positioning allows longer ice ball. Second probe placed 1 cm from first creates larger confluent ablation zone. Confirm both probes in perineural fat before resuming freeze.
6
Complications
Motor block, hematoma, neuritis, infection
Expected / Predictable Effects
- Foot drop (complete motor block) — expected with any perisciatic intervention; block lasts 4–12 h; cryoablation motor deficit lasts weeks; resolves as nerve regenerates at 1–2 mm/day
- Posterior thigh numbness — expected; may include PFCN distribution
- Transient leg weakness beyond foot drop — hip flexion, knee flexion may be affected
- Post-cryoablation pain flare (days 1–3) — inflammatory reaction; manage with NSAIDs; counsel patient before procedure
Complications
- Gluteal hematoma — most self-limited; compression if superficial; serial CT if expanding; transfuse if Hgb <8
- Infection / abscess — rare; antibiotics; CT-guided drainage if organized
- Neuritis / dysesthesia — partial ablation risk; burning, allodynia; manages with gabapentin; resolves over weeks to months
- Incomplete block with rebound pain exacerbation — acute worsening of symptoms immediately post-cryoablation (before Wallerian degeneration completes); manage with PCA ± hospital admission; resolves within 24 h typically
- Falls / injury — motor block makes ambulation unsafe; document fall risk and provide mobility aids before discharge
7
Post-Procedure Care
Fall precautions, motor exam, nerve recovery timeline
Immediate Recovery
- Motor exam: test dorsiflexion and plantar flexion before any weight-bearing or transfer
- Complete foot drop: patient must not ambulate unassisted — AFO brace and walker/crutches required
- Observe 2 h post-procedure (block: 1 h minimum; cryoablation: 2–4 h)
- Vital signs monitoring; hematoma check at probe sites (cryoablation)
- No driving until motor function confirmed fully returned
Cryoablation Recovery Period
- Warn patient: post-procedure pain exacerbation in first 24 h is common and expected (inflammatory response)
- Nerve regeneration: 1–2 mm/day; most patients recover motor function in 6–8 weeks (epineurium intact preserves regeneration pathway)
- PT/OT referral: exercises to maintain joint range of motion during denervation period; functional electrical stimulation for foot drop
- AFO brace for safe ambulation during recovery
- Gabapentin 300 mg TID if neuritis or dysesthesia
- Ibuprofen 600 mg TID × 5 days for post-cryoablation inflammation
Follow-up Schedule
| Timepoint | Assessment | Action |
|---|---|---|
| 24–48 h | Phone check — post-cryoablation pain flare | Pain control adjustment; confirm safe ambulation; PCA if admitted |
| 2 weeks | Clinic visit — pain diary review, motor exam | VAS score; document motor recovery; PT progress |
| 6 weeks | Full motor/sensory re-exam | Confirm nerve regeneration underway; reassess need for AFO |
| 3 months | Outcome assessment | If pain returns: cryoablation can be safely repeated (epineurium intact) |
8
Pearls & Pitfalls
Technique refinements and critical errors to avoid
Technique Pearls
✦
Always perform an ultra-short-acting diagnostic block (lidocaine alone) before committing to cryoablation — confirms the sciatic nerve as the pain generator and allows patient to experience the expected motor deficit before committing to weeks of foot drop from cryo.
✦
Cryoablation is preferred over chemical neurolysis (alcohol, phenol) for benign sciatica and phantom limb pain: reversible (epineurium preserved allows nerve regeneration), repeatable, lower neuritis risk, and less procedure-related pain vs. heat-based ablation.
✦
For piriformis syndrome: inject piriformis muscle belly (Botox + LA), not the sciatic nerve. The goal is muscle shrinkage to decompress the nerve, not direct nerve ablation. Adding perisciatic injection adjacent to the nerve in the same session addresses both the entrapment and the nerve inflammation.
✦
Adequate freeze time is critical for cryoneurolysis: ≥8 minutes per freeze cycle (2 cycles) ensures temperature ≤−40°C at nerve and Wallerian degeneration. Shorter freezes risk partial ablation — which can cause allodynia, dysesthesia, and incomplete or only short-term relief.
✦
Sciatic nerve fascicular architecture is visible on CT in the perisciatic fat — target perineural fat between fascicles and ischiorectal fat plane (subgluteal), NOT within the fascicular core. Perineural fat plane injection = adequate spread with less intraneural injury risk.
Critical Pitfalls
!
ALWAYS warn patients about expected temporary foot drop before any perisciatic procedure. Failure to counsel = unexpected motor loss = patient falls, injury, and loss of trust. Document the counseling explicitly in the consent note.
!
Never discharge a patient with complete foot drop without fall precaution plan in place — AFO brace, walker/crutches, someone at home, no driving. Motor block from bupivacaine lasts 4–12 h; cryoablation motor deficit lasts weeks.
!
Intraneural injection causes nerve injury. Sharp paresthesia down leg on injection = stop immediately. Withdraw and reposition. Confirm in perineural fat with CT before injecting.
!
Do not perform cryoablation without PT/OT plan in place for the recovery period. Weeks of foot drop without rehabilitation leads to secondary joint contracture and functional decline that outlasts the original pain problem.
9
References & Resources
Source material and related procedures
Primary References
- Prologo JD, Ray CE Jr., eds. Advanced Pain Management in Interventional Radiology: A Case-Based Approach. Thieme; 2024. DOI: 10.1055/b000000387
- Tran DQ, et al. Cryoneurolysis: a scoping review of the evidence. Reg Anesth Pain Med. 2021;46(3):255–263.
- Prologo JD, et al. Natural history of mixed and motor nerve cryoablation in humans — a cohort analysis. J Vasc Interv Radiol. 2020;31(6):912–916.
- Pezeshk P, Wadhwa V, Chhabra A. CT-Guided Peripheral Nerve Blocks. Chapter 31 in: Prologo JD, Ray CE Jr., eds. Advanced Pain Management in Interventional Radiology. Thieme; 2024.
- Kurup AN, et al. Neuroanatomic considerations in percutaneous tumor ablation. Radiographics. 2013;33(4):1195–1215.
9
References & Resources
Primary sources · Key data · Related procedures
Key Guidelines
- ASRA Practice Guidelines for Regional Anesthesia
- ISIS Guidelines for Peripheral Nerve Blocks
Primary References
- Prologo JD, Ray CE Jr., eds. Advanced Pain Management in Interventional Radiology. Thieme; 2024.
- Peng PW, Narouze S. Ultrasound-guided interventional procedures in pain medicine: a review of anatomy, sonoanatomy, and procedures. Reg Anesth Pain Med. 2009;34(5):458-474.
- Neal JM et al. ASRA Practice Advisory on Neurologic Complications in Regional Anesthesia. Reg Anesth Pain Med. 2015;40(5):401-430.